By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OncoMed Pharmaceuticals, Inc. 

800 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-995-8200 Fax: 650-298-8600



Start Up

Company News
Catastrophic Year for Bay Area's OncoMed (OMED) Continues as Lead Drug Comes Crashing Down in Phase II Study 5/8/2017 6:19:58 AM
OncoMed (OMED) To Report First Quarter Financial Results On May 8th, 2017 5/3/2017 8:51:17 AM
Beleaguered Bay Area Pharma OncoMed (OMED) Lays Off Half Its Workforce 4/24/2017 9:20:14 PM
When It Rains, It Pours: Bay Area's OncoMed (OMED) Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study 4/17/2017 6:50:29 AM
OncoMed (OMED) Tanks After Bayer (BAY) Opts Out of Two Drugs 4/10/2017 10:20:09 AM
OncoMed (OMED)’s Phase II Demcizumab Pancreatic Cancer Trial Misses Primary Endpoint 4/10/2017 10:16:32 AM
OncoMed (OMED) Presents Preclinical Data For Anti-TIGIT Program At The AACR Annual Meeting 2017 4/3/2017 1:29:18 PM
OncoMed (OMED) Announces Fourth Quarter And Full Year 2016 Financial Results 3/9/2017 10:46:57 AM
OncoMed (OMED) To Report Fourth Quarter And Year End Financial Results On March 8, 2017 3/2/2017 10:23:54 AM
OncoMed (OMED) Enrolls First Patient In Phase Ib Clinical Trial Of Its Anti-DLL4/VEGF Bispecific Antibody In Patients With Platinum-Resistant Ovarian Cancer 2/13/2017 8:12:53 AM